HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

iminobiotin

structure in first source

Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - Biotin: 4061
        iminobiotin: 5
Enzymes and Coenzymes: 1
- Coenzymes: 558
  - Biotin: 4061
    - iminobiotin: 5

Experts

1.	Aki, Sho: 1 article (01/2022)
2.	Ishii, Masazumi: 1 article (01/2022)
3.	Ishikawa, Shumpei: 1 article (01/2022)
4.	Kanai, Motomu: 1 article (01/2022)
5.	Kaneko, Yudai: 1 article (01/2022)
6.	Katoh, Hiroto: 1 article (01/2022)
7.	Kawamura, Takeshi: 1 article (01/2022)
8.	Kodama, Tatsuhiko: 1 article (01/2022)
9.	Miura, Mai: 1 article (01/2022)
10.	Ohkubo, Kei: 1 article (01/2022)

Related Diseases

1.	Heart Arrest (Cardiac Arrest) 01/01/2023 - "Neuroprotection after cardiac arrest with 2-iminobiotin: a single center phase IIa study on safety, tolerability, and pharmacokinetics."
2.	Hypothermia 02/27/2012 - "Potential neuroprotective strategies targeting different pathways leading to neuronal cell death in response to hypoxic-ischemic insult have been investigated: hypothermia, erythropoietin, iminobiotin, deferioxamine, magnesium, allopurinol, xenon, melatonin and statins. " 01/01/2012 - "Potential neuroprotective strategies targeting different pathways leading to neuronal cell death in response to hypoxic-ischemic insult have been investigated: hypothermia, erythropoietin, iminobiotin, deferioxamine, magnesium, allopurinol, xenon, melatonin and statins. "
3.	Neoplasms (Cancer) 01/01/2022 - "The AMDC developed against human epidermal growth factor receptor 2 (HER2) effectively killed cultured cancer cells using bis-iminobiotin conjugated to photo-activating silicon phthalocyanine. "
4.	Inflammation (Inflammations) 10/01/2010 - "In the early post HI phase, therapies can be concentrated on ion channel blockage (Xenon), anti-oxidation (allopurinol, 2-iminobiotin, and indomethacin), anti-inflammation (erythropoietin [EPO], melatonin), and anti-apoptosis (nuclear factor kappa B [NF-κB]and c-jun N-terminal kinase [JNK] inhibitors); in the later phase, therapies should be targeted to promote neuronal regeneration by stimulation of neurotrophic properties of the neonatal brain (EPO, growth factors, stem cells transplantation). "

Related Drugs and Biologics

1.	Xenon
2.	Melatonin
3.	Erythropoietin
4.	Allopurinol (Remid)
5.	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
6.	Magnesium
7.	JNK Mitogen-Activated Protein Kinases
8.	Intercellular Signaling Peptides and Proteins (Growth Factors)
9.	NF-kappa B (NF-kB)
10.	Ion Channels (Ion Channel)

Related Therapies and Procedures

1.	Transplantation
2.	Therapeutics